The role of protein kinases as key drivers of metabolic dysfunction-associated fatty liver disease progression: New insights and future directions
- 24 June 2022
- journal article
- review article
- Published by Elsevier in Life Sciences
- Vol. 305, 120732
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Higher Education, Malaysia (FRGS/1/2021/SKK0/USM/02/27)
- Universiti Sains Malaysia (304/PFARMASI/6315201)
This publication has 195 references indexed in Scilit:
- Diacylglycerol Activation of Protein Kinase Cε and Hepatic Insulin ResistanceCell Metabolism, 2012
- mTOR Signaling in Growth Control and DiseaseCell, 2012
- Excessive Hepatic Mitochondrial TCA Cycle and Gluconeogenesis in Humans with Nonalcoholic Fatty Liver DiseaseCell Metabolism, 2011
- Postprandial Hepatic Lipid Metabolism Requires Signaling through Akt2 Independent of the Transcription Factors FoxA2, FoxO1, and SREBP1cCell Metabolism, 2011
- Akt Stimulates Hepatic SREBP1c and Lipogenesis through Parallel mTORC1-Dependent and Independent PathwaysCell Metabolism, 2011
- JNK regulation of hepatic manifestations of the metabolic syndromeTrends in Endocrinology & Metabolism, 2010
- Akt2 Is Required for Hepatic Lipid Accumulation in Models of Insulin ResistanceCell Metabolism, 2009
- The inflammatory receptor CD40 is expressed on human adipocytes: contribution to crosstalk between lymphocytes and adipocytesDiabetologia, 2009
- Differential effects of JNK1 and JNK2 inhibition on murine steatohepatitis and insulin resistance†Hepatology, 2008
- AKT/PKB Signaling: Navigating DownstreamCell, 2007